198 Results

People

  1. Kelsen
    Kelsen
  2. Saltz
    Saltz
  3. Spriggs
    Spriggs
  4. Tong
    Tong
  5. Seidman
    Seidman
  6. Scher
    Scher
  7. Hudis
    Hudis
  8. Kemeny
    Kemeny
  9. Norton
    Norton
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)
  7. Center for Pancreatic Cancer Research (24)
  8. Genitourinary Oncology Service (24)
  9. Molecular Pharmacology and Chemistry Program Faculty (24)
  10. Breast Medicine Service (23)
  1. "infusions, intravenous"
Formats
  1. Journal Article (192)
  2. Conference Paper (5)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)

More Groups

People
  1. David Kelsen (16)
  2. Leonard Saltz (15)
  3. Nancy Kemeny (15)
  4. David Spriggs (14)
  5. William Tong (14)
  6. Andrew Seidman (13)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer (23)
  3. Investigational New Drugs (15)
  4. Clinical Cancer Research (9)
  5. Gynecologic Oncology (8)
  6. Cancer Chemotherapy and Pharmacology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Wiley Blackwell (28)
  3. Springer (26)
  4. Elsevier Inc. (23)
  5. Lippincott Williams & Wilkins (15)
  6. American Association for Cancer Research (14)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma
    Journal Article

    Sparano, J. A.; Lee, J. Y.; Kaplan, L. D.; Levine, A. M.; Ramos, J. C.; Ambinder, R. F.; Wachsman, W.; Aboulafia, D.; Noy, A.; Henry, D. H.; more...
    Blood (2010)

    Fulltext@MSK | Save
  • The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment
    Journal Article

    O'cearbhaill, R.; Zhou, Q.; Iasonos, A.; Hensley, M. L.; Tew, W. P.; Aghajanian, C.; Spriggs, D. R.; Lichtman, S. M.; Sabbatini, P. J.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
    Journal Article

    Moulder, S. L.; Holmes, F. A.; Tolcher, A. W.; Thall, P.; Broglio, K.; Valero, V.; Buzdar, A. U.; Arbuck, S. G.; Seidman, A.; Hortobagyi, G. N.
    Cancer (2010)

    Fulltext@MSK | Save
  • Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results
    Journal Article

    Morris, P. G.; Van Poznak, C.; Modi, S.; Mak, A. F.; Patil, S.; Larson, S.; Hudis, C. A.; Divgi, C.; Grewal, R. K.
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Advances in therapy: Eribulin improves survival for metastatic breast cancer
    Journal Article

    Morris, P. G.
    Anti-Cancer Drugs (2010)

    Fulltext@MSK | Save
  • Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: A randomized trial
    Journal Article

    Abou-Alfa, G. K.; Johnson, P.; Knox, J. J.; Capanu, M.; Davidenko, I.; Lacava, J.; Leung, T.; Gansukh, B.; Saltz, L. B.
    JAMA - Journal of the American Medical Association (2010)

    Fulltext@MSK | Save
  • Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash
    Journal Article

    Schilder, R. J.; Pathak, H. B.; Lokshin, A. E.; Holloway, R. W.; Alvarez, R. D.; Aghajanian, C.; Min, H.; Devarajan, K.; Ross, E.; Drescher, C. W.; more...
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Phase i study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma
    Journal Article

    Patel, P. H.; Senico, P. L.; Curiel, R. E.; Motzer, R. J.
    Clinical Genitourinary Cancer (2009)

    Fulltext@MSK | Save
  • Ancrod in acute ischemic stroke: Results of 500 subjects beginning treatment within 6 hours of stroke onset in the ancrod stroke program
    Journal Article

    Levy, D. E.; Del Zoppo, G. J.; Demaerschalk, B. M.; Demchuk, A. M.; Diener, H. C.; Howard, G.; Kaste, M.; Pancioli, A. M.; Spatareanu, C.; Wasiewski, W. W.
    Stroke (2009)

    Fulltext@MSK | Save
  • Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors
    Journal Article

    Ku, G. Y.; O'Reilly, E. M.; Saltz, L. B.; Schrag, D.; Maki, R. G.; Kelsen, D. P.; Ilson, D. H.
    Cancer Investigation (2009)

    Fulltext@MSK | Save